- NCIt
- C35427
Loading cancer entity…
Loading cancer entity…
Clinical trials
10 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06699979 | Multi-omics Study of Early-stage Lung Cancer With Distinct Phenotypes | recruiting | — | 300 | Central South UniversityOTHER | 1 | Jul 7, 2026 | clinicaltrials |
| NCT05053802 | Efficiency and Safety of Microwave Ablation Plus Immune Checkpoint Inhibitor for Patients With Multiple Primary Lung Cancer: A Open, Multi-center, Phase II Clinical Trial(MAGIC) | recruiting | Phase 2 | 146 | Shanghai Pulmonary Hospital, Shanghai, ChinaOTHER | 1 |
| Sep 23, 2021 |
| clinicaltrials |
Data updated 23 days agoSource updated Jul 7, 2026source: clinicaltrials